VSV. A. Sedinkin

V. A. Sedinkin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. A. Sedinkin has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hemocoagulation disorders in burn injury (review). Part 1

    by O.V. Kravets, V.V. Yekhalov, V.A. Sedinkin, Yu.O. Ploshchenko, O.V. Pylypenko, M.V. Zinenko

    Background. In cases of severe, extensive burns, the compensatory hemocoagulation mechanisms are disrupted, triggering processes of microcoagulation, and hemostasis disorders take the form of disseminated intravascular coagulation (DIC). Evidence collection. A retrospective literature review was conducted using a spatial-vector descriptive model, supplemented by a manual selection of the articles cited therein. A total of 36 contemporary sources published within the last 10 years were selected, of which 88.9 % were published within the last 5 years. Evidence synthesis. The fibrinolytic system plays a vital role in maintaining vascular patency by regulating thrombus formation and mediating its lysis. Burn injury triggers early fibrinolytic activation and a pro- and anti-inflammatory imbalance. A higher degree of fibrinolytic activity has been documented with increasing burn size and depth, followed by the development of fibrinolytic inhibition, which intensifies with increasing time to hospital admission. Increased thrombogenesis and fibrinolytic activity are observed throughout the inpatient treatment of burn patients, as elevated concentrations of plasmin-α2-antiplasmin, D-dimers and fibrin monomers have been detected during this period. It has been hypothesised that patients with burn injuries may exhibit three early fibrinolytic phenotypes, which may be associated with mortality to varying degrees. These include: hypofibrinolytic or fibrinolytic shutdown, normal or physiological, and hyperfibrinolytic. Secondary hyperfibrinolysis and pro- and anti-inflammatory imbalance ty­pically occur in the early stages of severe burns, and both are closely associated with a poor prognosis. This process is accompanied by a rapid increase in D-dimer levels, a decrease in fibrinogen (consumption coagulopathy) and prolonged thrombin time. Burn-induced coagulopathy and DIC are independent pathologies. Sepsis-induced DIC is the most common challenge in the differential diagnosis of patients with burns and usually manifests 5–10 days after severe burn injury. DIC is divided into two distinct categories: compensated latent and uncompensated overt one.

  • Organic heart damage in electrical injury

    by Kravets O.V., Melnik I.S., Sedinkin V.A., Stanin D.M., Yekhalov V.V.

    Electrical injuries represent one of the contemporary problems in healthcare, often associated with high morbidity and mortality. Myocardial morphological damage can be caused by electrical injury and is found in 3.2% of victims. Evidence Collection. Literature sources were included in the study if they: 1) were published in Ukrainian, English, or Spanish; 2) reported cardiac arrhythmias associated with electrical injury; 3) provided information on the prevalence of organic myocardial cardiac lesions in electrical injury; 4) used an observational design (cohort or cross-sectional). Evidence Synthesis. A number of mechanisms of myocardial damage in electrical injury have been described. These include direct thermal damage, induction of coronary artery spasm, ischemia secondary to arrhythmic hypotension, acute hypertension due to chemoreceptor stimulation, catecholamine-mediated damage, and ischemia in the coronary artery basin as a component of generalized injury. The degree of external skin damage should not be used to determine the extent of internal injury, as the current flows through the body along various pathways depending on tissue resistance, contact surface area, and the volume of affected tissue. Patients with electrical injury are prone to developing myocardial infarction, considering the damage caused by the current at the level of the vascular intima and the occurrence of thrombosis. Myocardial infarction can be caused by spasm of the coronary arteries or their occlusion by blood clots. Acute tissue ischemia resulting from spasm of the smooth vascular muscles plays a significant role in the mechanism of these conditions. Electricity can lead to focal or diffuse heart damage and often causes necrosis involving the myocardium, nodal tissue, conduction pathways, and coronary arteries. A 24-hour observation period under continuous cardiac monitoring is currently recommended, even for asymptomatic patients without prior predisposing conditions. An ele­vated troponin level for diagnosing electrical cardiac injury mostly lacks fundamental clinical significance. Conclusions. Electrical damage to the cardiovascular system is accompanied by serious life-threatening complications, including the possibility of long-term ones. Cardiac monitoring in victims of electric shock should be performed for at least 24 hours.

  • Anesthetic error. Part 3 (review)

    by Kravets O.V., Lavrova H.I., Ploshchenko Yu.O., Sedinkin V.A., Stanin D.M., Yekhalov V.V.

    Failure to perform checks, inattentiveness, lack of vigilance, and carelessness have been identified as causative factors for medical errors. In an era where patient knowledge and awareness of diseases and their treatments are expanding, clinicians need to be more vigilant to avoid tragic outcomes and litigation. Evidence of obtaining information. A retrospective information search of literary sources was performed using a spatial-vector model of a descriptor system based on classifiers, supplemented by a manual search of scientific publications. Materials and methods. Scientific literature information was obtained using the Scopus, CrossRef, Google Scholar, and PubMed search engines, supplemented by a manual search of cited articles. Evidence synthesis. The World Health Organization considers diagnostic errors (DE) to be one of the five leading causes of patient safety violations worldwide. In the practice of anesthesiology and intensive care, DEs occur at different stages of the diagnostic process: during the initial assessment and physical examination, during the selection and interpretation of diagnostic tests, or during follow-up and monitoring. For many reasons, diagnosis in primary care (i.e., at first contact, accessible, continuous, comprehensive, and coordinated health care) represents an area of ​​high risk for error. DEs include delayed, incorrect, and missed diagnosis. Diagnostic errors can result in harm through omissions (e.g., delaying or failing to treat an undiagnosed condition) and/or actions (e.g., treating an incorrectly diagnosed condition). Epidemiological data indicate that «classic» complications (failure or airway management error) have become less common. Not using alternative airway management methods was recognized as poor practice, a reminder of the importance of training to become expert in complex airway management guidelines. Airway modeling during tracheal intubation training engages staff of all grades, improves skill retention, and can highlight hidden errors and poor processes. The consequences of equipment failure during anesthesia can be extremely serious. Anesthesia machines have evolved to the point where it takes multiple simultaneous errors to cause harm to a patient. Simple vigilance, standardized protocol, and «think before you act» are key factors in avoiding treatment errors. Conclusion. Currently, anesthesia error remains an urgent problem of modern medicine. An anesthesia error can be directly related to the human factor, but can also depend on objective reasons. Most anesthesia errors are preventable.

  • Open Access

    Anticholinergic syndrome in the perioperative period (review). Part 2

    by O.V. Kravets, V.V. Yekhalov, V.A. Sedinkin, D.M. Stanin, D.A. Krishtafor, D.A. Martynenko

    The use of agents such as hyoscine and scopolamine for premedication has led anesthesiologists to consider central anticholinergic syndrome (ACS) as one of the important causes of delirium due to the previous anticholinergic effects of these agents. Not only antimuscarinic agents like atropine and scopolamine but also various other anesthetic drugs with anticholinergic effects can induce ACS, which may cause from 1 to 40 % of episodes of delayed awakening in the postoperative period. The frequency of ACS depends on the choice and dose of the anesthetic, the type of surgery, the patient’s condition, and diagnostic criteria. ACS after general anesthesia occurs in 8–12 % of patients, and after regional anesthesia combined with sedation, its frequency is 3.3–4 %. In sedated patients on prolonged mechanical ventilation, the syndrome occurs in about 5 % of cases. This syndrome is polyetiologic and can be caused by many drugs with different mechanisms of action. Most patients with central anticholinergic syndrome in the immediate postoperative period experience central nervous system depression, while those who present to emergency or psychiatric departments typically show agitation or delirium. The spectrum of anticholinergic delirium is a common complication after drug overdose. Patients with severe toxicity may experience significant distress and behavioral problems that often require pharmacological treatment. Seizures occur in about 2.5 % of patients, and cardiotoxic effects are sometimes also observed. In elderly patients, delirium is a common and serious side effect of surgical intervention and anesthesia, occurring at frequencies from 10.1 to 51 %. Postoperative delirium in older adults is often associated with persistent cognitive dysfunction, dementia, higher rates of institutionalization, and increased morbidity and mortality. Anticholinergic syndrome during the perioperative period is often undiagnosed and therefore inadequately treated. This toxidrome can manifest in polypharmacy, especially in the elderly, in neuro-muscular diseases, and hereditary predispositions. Perioperative ACS can be caused by many anesthetic drugs and especially their combinations. Trigger factors for ACS may include medications that can cause other toxidromes. Currently, our ability to treat ACS is significantly limited by the low availability of well-known antidotes and hemodialysis agents, which encourages the use of alternative intensive therapy options.

  • Open Access

    Albumin treatment of critical conditions on the example of pre-eclampsia

    by O. M. Klygunenko, O. V. Kravets, O. O. Zozulya, O. O. Marzan, Yu. O. Ploshchenko, V. A. Sedinkin, D. M. Stanin

    Despite the well-documented physicochemical and pharmacodynamic properties of albumin solutions and the availability of clinical guidelines for their use in critical conditions, several aspects of their application, particularly in the context of pre-eclampsia, remain a matter of clinical debate. Aim: to ascertain the effect of intravenous human albumin solution on the inflammatory process activity in the postpartum period in women with pre-eclampsia. Materials and methods. 60 women aged 18 to 40 years in the third trimester of pregnancy complicated by moderate or severe pre-eclampsia were assigned to 2 groups of 30 patients each according to the prespecified inclusion and exclusion criteria. Group I patients were given a standard therapy after delivery. Group II patients were treated with the same therapy combined with continuous infusions of 20 % albumin solution (8 ml/h – on day 1; 4 ml/h – on days 2 and 3) and furosemide (0.05 mg/kg/h – on day 1; 0.025 mg/kg/h – on days 2 and 3) for 72 hours. Serum concentrations of interleukins (IL)-6 and IL-10 were measured, and the IL-6 / IL-10 ratio (inflammation index) was calculated before the onset of labor, and on days 1 and 3 of the postpartum period. Results. The analysis has shown the inflammatory index of 120 % higher the normal in the third trimester of uncomplicated pregnancy, indicating a slight prenatal increase in inflammatory processes. Moderate or severe pre-eclampsia in the same period has been found to be accompanied by significantly increased IL-6/IL-10 ratios by 523.3–570.0 %, showing the significant activation of inflammatory processes. The use of albumin infusion in combination with low doses of furosemide according to the method developed by us has proven the possibility to correct the inflammatory process activity. So, with infusions on the 1st day postpartum, the IL-6 / IL-10 ratio was decreased and exceeded the norm for non-pregnant women by 866.7 % versus 1696.7 % in Group 1 women. On the 3rd day after childbirth, the inflammatory index exceeded the norm by only 116.7 % with intravenous albumin, while in Group 1 (control), it remained 730.0 % higher than the norm. Conclusions. Intravenous combination of albumin solution with furosemide in the postpartum period according to the authors’ method has helped to significantly reduce the inflammatory index in parturient women with pre-eclampsia.

  • Open Access

    Anticholinergic syndrome in the perioperative period (review). Part 1

    by O.V. Kravets, V.V. Yekhalov, V.A. Sedinkin, O.V. Pylypenko, D.A. Martynenko

    Anticholinergic syndrome is a febrile toxidrome characterized by the suppression of cholinergic neurotransmission in muscarinic receptors. A prerequisite for its development is that pharmacological agents must be lipophilic and capable of crossing the blood-brain barrier to block muscarinic cholinergic receptors. Triggers of anticholinergic toxidrome include alkaloids from over 2,000 species of plants and fungi, antipsychotics, antidepressants, antiparkinsonian drugs, antispasmodics, ocular and antihistamine medications, general and local anesthetics, which are often prescribed in combinations, although these drugs vary significantly in their anticholinergic effects within classes. Overdose of anticholinergic compounds can be accidental or intentional. Contributing factors include old age, central nervous system diseases, vitamin B1 deficiency, genetic predisposition, and polypharmacy. The mechanism of action of anticholinergic compounds is based on the antagonism of the neurotransmitter acetylcholine and its deficiency in the synaptic cleft of muscarinic anticholinergic receptors, which can be due to various factors. Symptoms caused by acetylcholine deficiency can be divided into peripheral and central, depending on whether the triggering substance can cross the blood-brain barrier. In anticholinergic syndrome, rhabdomyolysis is usually not present due to the rare occurrence of severe muscle tone increase or rigidity. The cumulative effect from taking several anticholinergic drugs, known as anticholinergic load, can negatively affect cognitive and physical functions and increase the risk of mortality.

  • Open Access

    Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 2

    by O.V. Kravets, V.A. Sedinkin, V.V. Yekhalov, O.V. Pylypenko, D.M. Stanin

    Currently, there is no generally accepted method for elimination of centrogenic hyperthermic reactions. In paroxysmal sympathetic hyperactivity, body temperature should be maintained in a safe normothermic range for at least the first few days. The potential benefits of treatment may result from three primary goals: elimination of triggering factors, mitigation of excessive sympathetic overload, and supportive therapy. Treatment involves reducing any external stimulation that can trigger paroxysmal episodes. Because fever is caused by a prostaglandin-induced shift in the hypothalamic “set point”, conventional nonsteroidal anti-inflammatory drugs inhibit prostaglandin synthesis, but centrogenic hyperthermic reactions are mostly resistant to antipyretic therapy. Physical cooling is used when medical treatment is ineffective. Endovascular cooling methods are more effective than external ones. Monotherapy for paroxysmal sympathetic hyperactivity is usually ineffective, so the possibility of using several drugs with different mechanisms of action should be considered. The use of moderate doses of several drug classes provides synergistic efficacy, reducing the toxicity of individual drugs. Multimodal treatment regimens are more effective than monotherapy. The lack of a generally accepted technique for elimination of centrogenic hyperthermic reactions requires further multicenter studies and the creation of appropriate clinical guidelines.

  • Open Access

    Polymer fume fever (review)

    by O.V. Kravets, V.V. Yekhalov, V.A. Sedinkin, M Zinenko

    Despite high chemical inertness of polytetrafluoroethylene, its pyrolysis, or the incomplete combustion reaction (oxidation-free thermal degradation), can lead to a rapid onset of flu-like symptoms when the resulting products are inhaled. This phenomenon is known as polymer fume fever and is most commonly observed in smokers. The hypothesis that ultrafine nanoparticles present in the air facilitate the transport of hydrofluoric acid molecules is the only standard that comes close to explaining this phenomenon. In some cases, when a toxic cause is not suspected, invasive tests are performed unnecessarily. There is a risk that the patient continues to be intoxicated and may develop pulmonary oedema or acute respiratory distress syndrome. There are no specific antidotes for Teflon pyrolysis products. The pervasive utilisation of polymeric products in industrial and domestic settings, in case of accidents or misuse, has the potential to exert a considerable negative influence on public health. Polymer fume fever is a rare, flu-like, occupational disease that is not always diagnosed promptly. A better understanding of the pathological process provides clinicians with the ability to make the correct diagnosis, properly educate patients, and ultimately achieve better treatment outcomes.


  • Open Access

    Problems of the state of the oral cavity and anesthetic care in users of various forms of cocaine (scientific and literary review)

    by O.V. Kravets, V.V. Yekhalov, V.A. Sedinkin, I.A. Romanyuta

    The prevalence of cocaine among the narcotic substances used by the population of Europe and America is second only to cannabinoids. Cocaine and crack use can cause various types of damage to the oral cavity, ranging from bad breath (halitosis) and gingivitis to cancer. These lesions are due to the anesthetic, vasoconstrictor, local prothrombotic properties of cocaine and its components in combination with cytotoxic effects and tissue damage associated with the method of use. Dentists quite often and treat cocaine users unknowingly, and they should be aware of the significant risks of possible problems and complications and be prepared to deal with them. Consuming this narcotic immediately before or after tooth extraction can cause excessive bleeding. Active cocaine users had significantly more complications related to anesthesia. Anesthesiologists should know the specifics of managing such patients, regardless of whether they are acutely intoxicated or suffering from the effects of chronic drug use. Monoamine oxidase inhibitors, class I antiarrhythmic drugs, and methadone in combination with cocaine lead to arrhythmias. The prescription of β-blockers should be avoided. The use of atropine and adrenaline can cause dangerous tachycardia in cocaine addicts. With general anesthesia during intubation, uncontrolled hypertension, arrhythmia and myocardial infarction, difficulty in mask ventilation and tracheal intubation due to inflammation, mucosal edema, defects of the palate, nasal membrane, pulmonary hypertension, which can complicate oxygenation or ventilation, may occur. Sympathomimetics are contraindicated if cocaine has been used within the last 24 hours. This must be explained to the patient (who must ensure that the drug was not used during this period), if local anesthesia with vasoconstrictors is indicated to reduce periodontal bleeding, since the use of a local anesthetic alone may not provide the necessary duration of anesthesia or the degree of hemostasis. Planned intervention using general anesthesia is possible at least 48 hours after the last use of cocaine (with certain risks), and optimally — after a week.

  • Open Access

    Trigger factors of general body overheating (scientific review)

    by O.V. Kravets, V.V. Yekhalov, V.A. Sedinkin, D.V. Myronov, D.A. Martynenko

    Global statistics show that approximately 489,000 people died annually from heat-related causes over the past two decades. Higher temperatures are associated with increased risk of mortality due to general accidents and four main subtypes, including road traffic accidents, falls, drownings, and unintentional injuries. Elevated temperatures and periods of anomalously hot weather already increase the global health hazard and cause significant economic losses. Mortality from general overheating is high and ranges from 33 to 80 %, with terminal events including shock, arrhythmias, myocardial infarction, renal failure, and neurological dysfunction. Residual neurological disorders were observed in 17 % of survivors. General overheating affects military personnel, athletes, workers in hot industries, and civilian populations exposed to or having formed risk factors for general inadvertent body overheating. Therefore, identifying and, where possible, preventing these risk factors is currently relevant. Exogenous hyperthermia contributing and predisposing factors are identified, timely detection and prevention of which will allow medical and social workers to limit the detrimental effects of hot conditions on public health.